NL-OMON31047已完成3 期
Doxycycline for Stabilization of Abdominal Aortic Aneurysms - Doxy-study
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients with an abdominal aortic aneurysm
- •The diameter should be 3.5 - 5.0 cm (Group A)
- •The diameter is > 5.5 cm and the patient is unfit for operation or refuses intervention (Group B)
- •Follow-up with ultrasound should be possible (obesity)
排除标准
- •Unable to comply with follow-up
- •Contra indications for doxycycline (excessive sun exposure)
- •Known impaired liver function (ALAT >3-fold normal values) or known kidney dysfunction (estimate clearance less than 40 ml/min)
- •Excessive sun exposure
研究者
相似试验
进行中（未招募）
不适用
Doxycycline for Stabilization of Abdominal Aortic AneurysmsAbdominal aortic aneurysmEUCTR2007-004124-20-NLMC
招募中
不适用
Pharmaceutical Aneurysm Stabilisation TrialAbdominal aortic aneurysm - Inflammation - Cardiovascular diseases - Metalloproteinases - Doxycycline - Pharmaceutical TreatmentNL-OMON23083uts Ohra300
已完成
2 期
Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical TrialAneurysmNCT01756833University of Maryland, Baltimore261
已完成
不适用
Treatment with doxycycline to promote the healing of chronic venous ulcer and markers of chronic venous insufficiencyCardiovascular: Venous ulcersCirculatory SystemVenous ulcersISRCTN28389872Department of Health60
进行中（未招募）
不适用
To investigate the effect of a medicine called doxycycline in people with evidence of stiffening of the heart muscleDiastolic dysfunctionMedDRA version: 14.1Level: PTClassification code 10052337Term: Diastolic dysfunctionSystem Organ Class: 10007541 - Cardiac disordersEUCTR2010-021664-16-IESolvotrin Innovations Ltd60